Brevan Howard Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-9,218	Closed	-$648K	–	1031
2024 Q3	$648K	Buy	+9,218	New	+$648K	﹤0.01%	558
2024 Q2	–	Sell	-9,197	Closed	-$803K	–	1032
2024 Q1	$803K	Buy	+9,197	New	+$803K	0.01%	276